Atlanta, Georgia – A major international investment is set to reshape Georgia’s life sciences landscape, as state leaders confirmed plans for a new pharmaceutical manufacturing facility backed by a $2 billion commitment. The project signals a significant step forward for both the state’s economy and its growing role in advanced medical innovation.
The announcement outlines plans for a large-scale biologics manufacturing site to be developed in Gwinnett County at the Rowen campus, a 2,000-acre hub designed to bring together research, education, and industry. Over the coming years, the initiative is expected to create 330 new jobs, adding to the region’s expanding workforce in the life sciences sector.
State officials framed the development as the result of ongoing collaboration, pointing to earlier discussions with company leadership that helped position Georgia as a strategic partner. The investment stands among the largest in the state’s history and reinforces its ambitions to become a center for cutting-edge biomedical work.
The company behind the project, a global biopharmaceutical firm headquartered in Belgium, already maintains a strong presence in the state through its North American base in Smyrna. That existing footprint, combined with decades of operational experience in the United States, played a role in the decision to deepen its investment locally. The company focuses on treatments in neurology and immunology, areas that continue to see rising demand and innovation.
Executives described the move as a long-term commitment aimed at strengthening manufacturing capabilities while supporting future research and development efforts. The facility is also projected to generate broader economic benefits, with estimates placing its total regional impact at around $5 billion.
The new site at Rowen is expected to operate with a modern, technology-driven approach. Plans call for the integration of artificial intelligence, robotics, and automation, alongside an emphasis on efficient resource use. As an anchor tenant, the company will help shape the identity of the campus as a collaborative environment where ideas and expertise can flow across disciplines.
Read also: Alpharetta prepares for start of major SR 400 project impacting daily commuters
State economic development officials highlighted the importance of partnerships in securing the project, noting coordinated efforts between regional organizations, workforce development programs, and infrastructure providers. They also emphasized Georgia’s growing reputation as a destination for talent and innovation, factors that continue to attract global companies looking to expand their reach and impact.
